Abstract
With the invasion of green tides and the increase of urban green areas worldwide, multimillion tons of Enteromorpha need to be reutilized. In this study, Enteromorpha prolifera powder is considered a promising biomass resource for the production of commercial chemical products production. Ilamycins, novel cyclic heptapeptides with significant anti-TB activities, are isolated from Streptomyces atratus SCSIO ZH16, a deep-sea-derived strain. Using EP powder as a nitrogen source, the production of ilamycins reached 709.97 mg/L through optimization of the nitrogen source using the engineered strain S. atratus SCSIO ZH16 ΔR. After mutant strain constructions and tests, strain S. atratus SCSIO ZH16 ΔR::bldD EP powder achieved a higher production titer of ilamycins. Furthermore, the production titer of ilamycins and ilamycin E reached 1561.77 mg/L and 745.44 mg/L, respectively, in a 5 L bioreactor. This study suggests that E. prolifera is a promising and eco-friendly nitrogen source for the production of ilamycins.
Similar content being viewed by others
Introduction
In the past 10 years, severe eutrophication of seawater has resulted in the occurrence of Enteromorpha prolifera (EP) green tides, which are harmful algal blooms causing significant damage to the economy and environment of coastal cities in Asia [22]. Due to its high organic matter content and abundant production, however, EP has the potential to be used as raw materials for digestion [13]. Carbohydrates in EP exist in the polymer forms of hexose and pentose, which can be subsequently converted into bioethanol or biohydrogen [3]. EP proteins serve as a source of N-containing valuable products and nutrients for humans or animals. They can also be hydrolyzed into amino acids and subsequently converted into commercial chemical products [11]. Therefore, the efficient reutilization and disposal of EP as a source of energy and materials can help mitigating greenhouse gas emissions. However, only a few studies have been reported on the application of EP [11]. Actinomycetes species are renowned for the capacity to produce a multitude of high-valued product, even using waste biomass [5, 12]. Previous studies have demonstrated that S. atratus SCSIO ZH16, isolated from deep-sea sediment in the South China Sea, exhibits advantages, including rapid growth, ease of cultivation, and stable metabolism, for the production of high-value products [19, 20]. Among the natural products from S. atratus SCSIO ZH16, nonribosomal peptides ilamycins, especially ilamycin E, show brilliant anti-tuberculosis properties [9], and require yield improvement for the realization of industrial production or process. By Plackett–Burman design model, single factor optimization, pH coordinated feeding and continuous pulse feeding, [7] achieved 415.7 ± 29.2 mg/L ilamycin E yield in a 300 L bioreactor. Our previous research also improved the production of ilamycin E from 13.51 to 762.50 mg/L in a 5 L bioreactor, and found the crucial role of nitrogen source on cellular growth of ZH16-ΔilaR and the production of ilamycins [24]. Soybean powder, the preferable nitrogen source identified, has obvious shortcomings, such as difficult to sterilize and high cost. Therefore, it is crucial to develop an efficient production process that can utilize inexpensive nitrogen sources to achieve massive production of ilamycin E.
Beside optimization of fermentation conditions, genetic modification is another powerful tool for the improvement of antibiotic-producing strains [2]. Commonly used targets in Streptomyces genetic modification include metabolism pathways that supply or shunt the precursors, resistance proteins that protect the host, modifying factors that determine the activity of enzymes, and regulators that promote or repress secondary metabolism, etc. [6]. Among them, genetic operation towards regulatory genes is a promising approach. For example, global regulator BldD dominates the process of morphology and secondary metabolism in multiple Actinomyces, and overexpression of bldD has boosted the production of daptomycin, avermectin and moenomycin [4, 10, 17]. Therefore, this study combined both fermentation condition optimization and strain genetic modification to enhance the yield of ilamycins.
By utilizing EP powder as a cost-effective, environment friendly nitrogen source, the engineered strain S. atratus SCSIO ZH16 ΔilaR::bldD with extreme environment tolerance achieved a production of 1561.77 mg/L of ilamycins and 745.44 mg/L of ilamycin E in a 5 L bioreactor.
Results and discussion
Nitrogen sources screenings for the production of ilamycins
Nutrients so called nitrogen sources are required for forming nitrogenous cell components or metabolites, selection of which is essential for fermentation optimization. Due to the specific impact of any kind of organic nitrogen source on the growth of bacteria and synthesis of natural products, one bacterium or its genetic mutant has unique preference for organic nitrogen sources. Previous studies indicated the significant effect of the selection of organic nitrogen source on the yield of ilamycins in S. atratus SCSIO ZH16 ΔilaR [7, 24]. In view of this, this study started with the systematic screening of composite nitrogen sources on S. atratus SCSIO ZH16 ΔilaR (ΔR for short), an engineering strain that accumulates highly anti-tuberculosis activity component ilamycin F and ilamycin E1/E2, for the production of ilamycins.
Given the shortcomings of soybean powder, currently used nitrogen source for ilamycins fermentation, such as difficult to sterilize, foaming properties, complicated production process and high cost, we attempted to seek a superior alternative. The 14 alternative nitrogen sources including EP powder, corn steep liquor, two types of yeast extract powder (Angel and OXOID), polypeptone, peptone, yeast extract paste, malt extract, beef extract, bacterial peptone, fish peptone, tryptone, acid-hydrolyzed casein and soybean flour were selected for screening. The results showed that soybean powder, bean flour and EP powder were the top three high-yielding nitrogen sources (Fig. 1A). Compared with the other two materials, EP powder has significant advantages in terms of environmental friendliness and cost.
Utilization of EP powder for the ilamycins production in S. atratus SCSIO ZH16 ΔR. A Yield of ilamycins in media with different complex nitrogen sources. 1, Angel yeast extract powder; 2, acid-hydrolyzed casein; 3, tryptone; 4, corn steep liquor; 5, fish peptone; 6, bacterial peptone; 7, OXOID yeast extract; 8, yeast extract paste; 9, polypeptone; 10, peptone; 11, malt extract; 12, beef extract; 13, Enteromorpha prolifera; 14, bean flour; 15, soybean powder. B Effect of different combinations of carbon and nitrogen sources on the yield of ilamycins. 1, soluble starch; 2, soybean powder; 3, EP powder, ‘(Acid)’ means after acid hydrolysis; 4, corn steep liquor, NaNO3 and (NH4)2SO4. Error bars represent the standard deviations from three independent biological replicates. **: P < 0.01 (Student’s t test). C Weight ratio and D molality of N, C, H in EP powder
To validate whether EP powder mainly function as the nitrogen source in fermentation, eight media varying in carbon and nitrogen sources (bottom of Fig. 1B, named M1–M8) were designed and tested. As shown in Fig. 1B, compared to M1 containing soybean powder, ilamycins yield of M2 containing EP powder decreased slightly (from 1044.97 to 709.97 mg/L), while M4 containing neither soybean powder nor EP powder produced only 117.73 mg/L ilamycins. Take the shortcomings of soybean powder into account, the yield reduction of replacing soybean powder with EP powder can be acceptable. In addition, when S. atratus was cultured in media containing both soybean powder (N source) and EP powder but lack of soluble starch (C source) (named M3 and M6), the production of ilamycins were extremely low, which means that EP powder cannot replace soluble starch as a carbon source, regardless of whether or not it has been subjected to acid hydrolysis. Besides, the ilamycins yield of M2 is 42.7-fold higher than that of original medium Am3 (Additional file 1: Fig. S1). These results demonstrate that selection of nitrogen source is crucial for the production of ilamycins, and EP powder can be used as a good nitrogen source substitute for cellular growth (Additional file 1: Fig. S2), primary and secondary metabolism flux regulation, and ilamycins biosynthesis of ΔR. In addition, macroalgal blooms result from eutrophication, and the consequent oxygen consumption, which threats the survival of other marine plants and animals while not release any toxic compounds [21]. Therefore, E. prolifera is non-toxic and can be utilized as sources of protein and bioactive compounds in formulated feeds, or processed into snacks and condiments [11]. Then, the results also showed that the yield in M8 definitely decreased compared to M2, which is main due to the absence of corn steep flour, because the trace element provided by corn steep liquor, including a variety of amino acids, inorganic salts and vitamins, are significant for the production of natural products [16]. What is more, the results of M5 and M7 add to the fact that the combination of the major organic nitrogen source EP powder, the carbon source soluble starch, the easy-utilized nitrogen sources corn steep flour, NaNO3 and (NH4)2SO4 are the most basic important requirements for production of ilamycins.
The analysis of element components on EP powder shows that the weight ratio of N, C and H elements are 3.69%, 29.58% and 5.46%, respectively, which converted to the molality ratio is 1:9:21 (Fig. 1C, D). The reason for the inability of EP powder to be utilized as a carbon source may due to that the main component of carbon source in EP powder is algal polysaccharides, which is not suitable for Streptomyces. In a word, when goes to industrial scale production, EP powder is a considerable environment friendly nitrogen source, and the leftover waste after product recovery may be treated as fertilizer or innocuous solid waste. As soluble starch is not considered as an ideal carbon source for industrial fermentation, we are currently attempting to screen alternative carbon sources and hope this issue would be solved in future.
Construction of ilamycins high-yield strains
Given that the substitution of nitrogen source with EP powder caused decrease in ilamycins production to some extent, we turned to construct mutant stains that can increase ilamycins productions of S. atratus in EP powder-containing media EP powder. A screening on genes belonging to four function categories were performed:
-
(1)
Self-resistance Ilamycins resistance genes ilaJ and ilaK inside of the biosynthesis gene cluster and putative resistance gene bla (RS37870) were overexpressed by separately integrating them into the ΦC31 attB site. None of these overexpression strains led to enhancement in ilamycins production (Fig. 2). To be noticed, it has been found that overexpression of ilaJ, ilaK and bla promoted the production of ilamycin D and ilamycins C1/C2 in wild type (WT) strain (Additional file 1: Fig. S4), but these compounds have low anti-tuberculosis activity. Therefore, the cause of failure in ilamycins production improvement through ilaJ, ilaK and bla overexpression might be the specific transport towards ilamycin D and ilamycins C1/C2.
-
(2)
Biosynthesis pathway Two key enzymes from shikimate pathway, chorismate synthase (CS) and shikimate dehydrogenase (SKD), were selected for overexpression, since they participate in the supply of ilamycins biosynthesis precursor tryptophan and tyrosine. Beside precursor supply consolidation, atr23 (encoding nonribosomal peptide synthetase) from the biosynthesis gene cluster of atratumycin was deleted by CRISPR–Cas9 to weaken the competitive pathway. Atratumycin is a decapeptide composed of amino acids, including tryptophan and tyrosine [14], its biosynthesis, therefore, theoretically inhibits the biosynthesis of ilamycins through competition of precursors. However, no enhancement of ilamycins yield occurred in strains ΔR::CS, ΔR::SKD and ΔRΔatr23 (Fig. 2). It can be speculated that the supply of tryptophan and tyrosine in strain ΔR is enough for ilamycins biosynthesis, and the shunt pathway for atratumycin biosynthesis is relative weak.
-
(3)
Regulator Manipulation towards regulator is a well-validated approach for yield enhancement of natural products [15, 23], and also adopted in this study. Well-known regulatory genes related to morphology development and secondary metabolism, such as bldD, arpA and rok7B7 etc., were overexpressed in strain ΔR, to explore the possibility of ilamycins yield increasement. Among the nine overexpression strains, ΔR::bldD showed an obvious enhancement in ilamycins yield by 58.13% to 900.04 mg/L (Fig. 2). It is noteworthy that, the effect evaluations of these regulatory genes were all carried out through gene overexpression because of the extremely low efficiency of CRISPR/Cas9 method in S. atratus. Further assessment on regulatory genes can be performed after optimization of the CRISPR/Cas9 method.
-
(4)
Protein modification As nonribosomal peptides, efficiently biosynthesis of ilamycins requires a protein modification executed by phosphopantetheinyl transferase (PPtase) to activate carrier proteins [1]. Therefore, overexpression of PPtase has successfully improved the production of multiple antibiotics [18]. In this study, two commonly used heterologous PPtase genes from Bacillus subtilis (sfp) and Streptomyces verticillus (svp), and three native PPtase genes (RS01025, RS31655 and RS38670), were expressed in strain ΔR. None of the mutant strains based on PPtase genes led to enhancement of ilamycins yield (Fig. 2), indicating that the modification level of carrier proteins in strain ΔR is not a limiting factor for ilamycins biosynthesis.
In total, as the only high-yield strain screened, strain ΔR::bldD is used for the subsequent mechanism analysis and fermentation optimization.
Mechanism analysis of BldD regulating ilamycins biosynthesis
To understand the regulatory mechanism of BldD on the biosynthesis of ilamycins, the transcription level of biosynthetic genes of ilamycins were first examined. Genes inside ilamycins biosynthesis cluster form six operons: ilaAB, ilaC, ilaDEFGHIJKLMNOP, ilaQ, ilaRS and ilaT (Fig. 3A), and the leading gene of each operon were selected for qRT-PCR detection. Since regulatory genes ilaA and ilaB have opposite functions, their transcriptional levels were both tested. RNA from strains ΔR and ΔR::bldD cultured after 48 and 72 h was extracted and detected by qRT-PCR. As shown in Fig. 3B, the transcription level of tested genes was decreased at 48 h, whereas up-regulated at 72 h. According to growth curve and ilamycins yield curve analyzed previously [1: Table S1.
Fermentation in a stirred-tank 5-L bioreactor
The optimized fermentation medium and parameters were conducted in a 5 L bioreactor (Shanghai Guoqiang Biochemical Engineering Equipment Co., Ltd., Shanghai, China), which was equipped with pH, temperature and pO2 probes. 300 mL of seed culture was incubated for 4 days and then inoculated into the stirred-tank bioreactor containing 2.7 L fermentation media. The aeration was kept at 1.0–2.0 vvm (air/culture volume/min) and the agitation speed was set from 200 to 600 rpm, linking with the dissolved oxygen level. During the fermentation process, broth was cultivated at 26 ℃ for 240 h and samples were taken every 24 h to detect ilamycins production, dry weight and residual sugar of the broth.
Analytical methods of ilamycins
As the EP powder, soybean powder and calcium carbonate were insoluble in water, it is hard to detect the dry cell weight, dry weight of mixed non-soluble particles and biomass were used instead. The supernatant and solid substances were separated by vacuum filtration. After 24 h of drying in a 50 ℃ oven, the dry weight was calculated using subtraction method. For the extraction and quantitative analysis of ilamycins by HPLC, detailed steps were performed as described previously [24]. The dried extracts of the fermentation products were dissolved with accurate amount of methanol and centrifuged for 5 min at 10,000 rpm followed by filtration of 0.22 μm membranes. Reversed phase column Agilent ZORBAX Eclipse XDB-C18 (4.6 mm × 150 mm, 5 μm) with UV detection at 210, 280, 354 nm was used to detect ilamycins under the following program: solvent system (solvent A, water supplemented with 0.1% acetic acid; solvent B, acetonitrile); 15% B to 71% B (linear gradient, 0–10 min), 71% B to 85% B (linear gradient, 10.0–11.5 min), 85% B (11.5–20.0 min), 85% B to 90% B (linear gradient, 20.0–20.1 min), 90% B (20.1–25.1 min), 90% B to 15% B (linear gradient, 25.1–26.0 min), 15% B (26.0–30.0 min); the flow rate was set as 1 mL/min.
The concentration of residual sugar in the broth were determined by a Total Carbohydrate Content Assay Kit (Solarbio Science & Technology Co., Ltd., Bei**g, China). The content of carbon and nitrogen elements in the E. prolifera was detected through an Elemental analyzer (ELEMENTAR, German).
Scanning electron microscope (SEM)
The S. atratus mutant strains were cultured on YMS medium at 28 ℃, and a 2 mm × 2 mm area of the strains was harvested from the plate at 3, 4, 5, 6, 7, 8 and 9 d by scalpel. The samples were soaked with 2.5% glutaraldehyde at 4 ℃ overnight and then dried naturally. Finally, the observation of the dehydrate cells were conducted on a S3400-N scanning electron microscopy (Hitachi, Tokyo, Japan) according to standard procedures.
Availability of data and materials
Data will be made available on request.
References
Beld J, Sonnenschein EC, Vickery CR, Noel JP, Burkart MD. The phosphopantetheinyl transferases: catalysis of a post-translational modification crucial for life. Nat Prod Rep. 2014;31:61e108.
Bu QT, Li YP, **e H, Li JF, Lv ZY, Su YT, Li YQ. Rational engineering strategies for achieving high-yield, high-quality and high-stability of natural product production in actinomycetes. Metab Eng. 2021;67:198–215.
Chia SR, Ong HC, Chew KW, Show PL, Phang SM, Ling TC, Nagarajan D, Lee DJ, Chang JS. Sustainable approaches for algae utilisation in bioenergy production. Renew Energ. 2018;129:838–52.
Chng C, Lum AM, Vroom JA, Kao CM. A key developmental regulator controls the synthesis of the antibiotic erythromycin in Saccharopolyspora erythraea. Proc Nat Acad Sci U S A. 2008;105(32):11346–51.
Cuebas-Irizarry MF, Grunden AM. Streptomyces spp as biocatalyst sources in pulp and paper and textile industries: biodegradation, bioconversion and valorization of waste. Microb Biotechnol. 2023. https://doi.org/10.1111/1751-7915.14258.
Del Carratore F, Hanko EKR, Breitling R, Breitling R, Takano E. Biotechnological application of Streptomyces for the production of clinical drugs and other bioactive molecules. Curr Opin Biotechnol. 2022;77: 102762.
Fan Z, Tong N, Zhuang Z, Ma C, Ma J, Ju J, Duan Y, Zhu X. Medium optimization and subsequent fermentative regulation enabled the scaled-up production of anti-tuberculosis drug leads ilamycin-E1/E2. Biotechnol J. 2021;17(4):2100427.
Huang H, Zheng G, Jiang W, Hu H, Lu Y. One-step high-efficiency CRISPR/Cas9-mediated genome editing in Streptomyces. Acta Bioch Bioph Sin. 2015;47(4):231–43.
Ma J, Huang H, **e Y, Liu Z, Zhao J, Zhang C, Jia Y, Zhang Y, Zhang H, Zhang T, Ju J. Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents. Nat Commun. 2017;8(1):391.
Makitrynskyy R, Tsypik O, Nuzzo D, Paululat T, Zechel DL, Bechthold A. Secondary nucleotide messenger c-di-GMP exerts a global control on natural product biosynthesis in streptomycetes. Nucleic Acids Res. 2020;48(3):1583–98.
Øverland M, Mydland LT, Skrede A. Marine macroalgae as sources of protein and bioactive compounds in feed for monogastric animals. J Sci Food Agri. 2019;99(1):13–24.
Schalchli H, Hormazábal E, Astudillo Á, Briceño G, Rubilar O, Diez MC. Bioconversion of potato solid waste into antifungals and biopigments using Streptomyces spp. PLoS ONE. 2021;16(5): e0252113.
Shi Y, Ge Y, Chang J, Shao HB, Tang YL. Garden waste biomass for renewable and sustainable energy production in China: potential, challenges and development. Renew Sust Energ Rev. 2013;22:432–7.
Sun C, Yang Z, Zhang C, Liu Z, He J, Liu Q, Zhang T, Ju J, Ma J. Genome mining of Streptomyces atratus SCSIO ZH16: discovery of atratumycin and identification of its biosynthetic gene cluster. Org Lett. 2019;21(5):1453–7.
Wang R, Kong F, Wu H, Hou B, Kang Y, Cao Y, Duan S, Ye J, Zhang H. Complete genome sequence of high-yield strain S lincolnensis B48 and identification of crucial mutations contributing to lincomycin overproduction synth. Syst Biotechnol. 2020;5(3):37–48.
Wu W, Pang B, Yang R, Liu G, Ai C, Jiang C, Shi J. Improvement of the probiotic potential and yield of Lactobacillus rhamnosus cells using corn steep liquor. LWT-Food Sci Technol. 2020;131: 109862.
Yan H, Lu X, Sun D, Zhuang S, Chen Q, Chen Z, Li J, Wen Y. BldD, a master developmental repressor, activates antibiotic production in two Streptomyces species. Mol Microbiol. 2020;113(1):123–42.
Yan X, Zhang B, Tian W, Dai Q, Zheng X, Hu K, Liu X, Deng Z, Qu X. Puromycin A, B and C, cryptic nucleosides identified from Streptomyces alboniger NRRL B-1832 by PPtase-based activation. Synth Syst Biotechnol. 2018;3(1):76–80.
Yang Z, Sun C, Liu Z, Liu Q, Zhang T, Ju J, Ma J. Production of antitubercular depsipeptides via biosynthetic engineering of cinnamoyl units. J Nat Prod. 2020;83(5):1666–73.
Yang Z, Wei X, He J, Sun C, Ju J, Ma J. Characterization of the noncanonical regulatory and transporter genes in atratumycin biosynthesis and production in a heterologous host. Mar Drugs. 2019;17(10):560.
Zhao J, Jiang P, Liu Z, Wei W, Lin H, Li F, Wang J, Qin S. The yellow sea green tides were dominated by one species, Ulva (Enteromorpha) prolifera, from 2007 to 2011. Chin Sci Bull. 2013;58(19):2298–302.
Zhao S, Li P, Fang H, Song L, Li D, Liu R, Niu Q. Enhancement methane fermentation of Enteromorpha prolifera waste by Saccharomyces cerevisiae: batch kinetic investigation, dissolved organic matter characterization, and synergistic mechanism. Environ Sci Pollut R. 2020;27(14):16254–67.
Zhou Q, Ning S, Luo Y. Coordinated regulation for nature products discovery and overproduction in Streptomyces. Synth Syst Biotechnol. 2020;5(3):49–58.
Zhu Y, Zheng G, **n X, Ma J, Ju J, An F. Combinatorial strategies for production improvement of anti-tuberculosis antibiotics ilamycins E1/E2 from deep sea-derived Streptomyces atratus SCSIO ZH16 ΔilaR. Bioresour Bioprocess. 2022;9(1):111.
Acknowledgements
We thank Professor Haizhen Wu from East China University of Science and Technology for kindly providing us with the strain, E. coli DH5α and E. coli S17-1. We also thank Professor Xudong Qu, from Shanghai Jiao Tong university for kindly providing us with the plasmid pWHU2449.
Funding
This work was funded the National Key R&D Program of China (Nos. 2019YFC0312504, 2018YFC1706206), the Excellent Youth Scholars of Anhui Provincial Education Department (2022AH030097). This work was also supported by the Open Research Fund Program of State Key Laboratory of Bioreactor Engineering and Shanghai Collaborative Innovation Center for Biomanufacturing Technology.
Author information
Authors and Affiliations
Contributions
YXJ: investigation, formal analysis, data curation, writing—original draft, visualization, methodology. GFZ: investigation, validation, methodology, writing—review and editing, visualization. CLC: investigation, validation. NY: investigation, validation. XJX: supervision, project administration. HW: supervision, project administration. MZ: supervision, project administration. JYM: resources. JHJ: resources. RW: conceptualization, methodology, resources, writing—review and editing. FLA: conceptualization, writing—review and editing, visualization, supervision, project administration, funding acquisition.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Additional file 1:
Fig. S1. Comparison of ilamycins production of ΔR strain in M2 medium and Am3 medium. Fig. S2. Effect of different combinations of carbon and nitrogen sources on the dry weight of ΔR strain. Fig. S3. Reducing sugar, total sugar, nitrogen and oil content in EP powder before and after sterilization. Fig. S4. Effect of overexpressing ilaJ and ilaK on the production of ilamycins in wild type strain. Fig. S5. Macroscopic and microscopic morphological changes of strains ΔR and ΔR::bldD. Fig. S6. Effects of A pH, B temperature, C inoculation amount, D inoculation time, E addition amount of EP powder, F rotational speed, G liquid volume and (H) Zn2+ concentration on dry weight of ΔR::bldD strain fermentation broth. Table S1 Primers used in this study.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Jiang, YX., Zheng, GF., Chen, LC. et al. Efficient ilamycins production utilizing Enteromorpha prolifera by metabolically engineered Streptomyces atratus. Biotechnol Biofuels 16, 151 (2023). https://doi.org/10.1186/s13068-023-02398-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s13068-023-02398-w